Article Details
Retrieved on: 2018-01-02 22:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Existing investors <b>New Enterprise Associates</b>, Novo A/S, NanoDimension and Flagship Pioneering also participated. With the financing, Dr. Guido Magni, Partner at Versant Ventures and former Global Head of the Medical Science Department of Roche Pharmaceuticals joined the Tarveda board.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here